FilingReader Intelligence
Sun Pharma emphasizes sustainability, ethics in FY25 report
July 4, 2025 at 02:09 PM UTC•By FilingReader AI
** Sun Pharmaceutical Industries has released its Business Responsibility and Sustainability Report for fiscal year 2024-25, emphasizing its commitment to environmental, social, and governance (ESG) principles. The report highlights the company's inclusion in the S&P Global Sustainability Yearbook 2025, placing it in the top 5% of pharmaceutical companies globally as assessed by S&P.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
BSE:SUNPHARMA•Bombay Stock Exchange
News Alerts
Get instant email alerts when Sun Pharmaceutical Industries publishes news
Free account required • Unsubscribe anytime